LOS ANGELES, CA, Jan. 11, 2018 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), a clinical-stage developer of non-invasive electroceuticals for the treatment of central nervous system (CNS) disorders, today announced it is working with ShareIntel – Shareholder Intelligence Services to continue its commitment to protecting its shareholders and maximizing shareholder value. ShareIntel offers unprecedented access and insight into broker-dealer, clearing firm and shareholder position movement. ShareIntel utilizes a patented process called DRIL-DownTM to aggregate and analyze historic repository dataRead more
- FTE Awarded $27.5 Million in Contracts by Two Multi-National Fortune 500 Companies
- Sugarmade Comments on California’s First Month of Recreational Cannabis Legalization – Still Bottlenecks But Plays Well Into Sugarmade’s Corporate Initiatives
- Sack Lunch Productions (Ticker: SAKL) – Specializing in Event Productions Around the World
- Goldman Small Cap Research Issues Research Report On Rocky Mountain High Brands, Inc.
- Marijuana Company of America Launches New CBD Product hempSMART™ Pet Drops
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More